PubRank

Rainer Haas

Author PubWeight™ 187.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003 3.00
2 Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 2002 2.80
3 Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 2005 2.68
4 Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2007 2.41
5 Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003 2.28
6 VirB11 ATPases are dynamic hexameric assemblies: new insights into bacterial type IV secretion. EMBO J 2003 2.23
7 Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood 2004 2.23
8 Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood 2006 2.15
9 A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol 2003 2.11
10 The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood 2008 2.01
11 Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe 2008 1.96
12 Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog 2009 1.82
13 Strain-specific genes of Helicobacter pylori: genome evolution driven by a novel type IV secretion system and genomic island transfer. Nucleic Acids Res 2010 1.80
14 Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Haematologica 2008 1.74
15 Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol 2002 1.72
16 SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog 2006 1.68
17 The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia. Cancer 2006 1.65
18 Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci U S A 2007 1.58
19 Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation. Leuk Lymphoma 2011 1.58
20 Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells. Blood 2012 1.57
21 Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma. Leuk Lymphoma 2007 1.50
22 Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 2006 1.48
23 Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals. Leuk Res 2003 1.48
24 Delayed diagnosis and complications of Fanconi anaemia at advanced age--a paradigm. Br J Haematol 2006 1.48
25 The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome. Haematologica 2009 1.46
26 Impact on survival of different treatments for myelodysplastic syndromes (MDS). Leuk Res 2009 1.45
27 Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun 2002 1.43
28 Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. Biol Blood Marrow Transplant 2011 1.43
29 Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry. Leuk Res 2011 1.42
30 Protein subassemblies of the Helicobacter pylori Cag type IV secretion system revealed by localization and interaction studies. J Bacteriol 2008 1.38
31 CagA tyrosine phosphorylation and interleukin-8 induction by Helicobacter pylori are independent from alpAB, HopZ and bab group outer membrane proteins. Int J Med Microbiol 2002 1.34
32 Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes. Cancer 2007 1.34
33 BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J Biol Chem 2011 1.33
34 Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J Virol Methods 2002 1.33
35 Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood 2002 1.32
36 The novel Helicobacter pylori CznABC metal efflux pump is required for cadmium, zinc, and nickel resistance, urease modulation, and gastric colonization. Infect Immun 2006 1.31
37 Functional and topological characterization of novel components of the comB DNA transformation competence system in Helicobacter pylori. J Bacteriol 2006 1.31
38 Myelodysplastic syndromes in patients younger than age 50. J Clin Oncol 2006 1.27
39 No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004 1.27
40 Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol 2004 1.27
41 Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia. Ann Hematol 2005 1.26
42 Characterization of two cryptic Helicobacter pylori plasmids: a putative source for horizontal gene transfer and gene shuffling. J Bacteriol 2002 1.23
43 Myelodysplastic syndromes: diagnosis, prognosis, and treatment. Dtsch Arztebl Int 2013 1.21
44 Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc Natl Acad Sci U S A 2007 1.20
45 A C-terminal translocation signal is necessary, but not sufficient for type IV secretion of the Helicobacter pylori CagA protein. Mol Microbiol 2006 1.20
46 Plasticity of repetitive DNA sequences within a bacterial (Type IV) secretion system component. J Exp Med 2003 1.19
47 Biochemical and functional characterization of Helicobacter pylori vesicles. Mol Microbiol 2010 1.18
48 Sequencing, annotation, and comparative genome analysis of the gerbil-adapted Helicobacter pylori strain B8. BMC Genomics 2010 1.18
49 FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. PLoS One 2013 1.17
50 Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr Opin Microbiol 2005 1.17
51 Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med 2008 1.15
52 Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect Immun 2009 1.15
53 Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori. Curr Top Microbiol Immunol 2009 1.14
54 Helicobacter pylori cag-Pathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PLoS One 2009 1.14
55 Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa. Glycobiology 2009 1.14
56 Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood 2004 1.12
57 The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of the CagA effector protein. Microbiology 2007 1.11
58 Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. Int J Med Microbiol 2002 1.09
59 Two-component systems of Helicobacter pylori contribute to virulence in a mouse infection model. Infect Immun 2003 1.08
60 Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation. Br J Haematol 2011 1.08
61 Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol 2006 1.08
62 Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 2005 1.07
63 Therapy-related myeloid neoplasms following treatment with radioiodine. Haematologica 2011 1.06
64 Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem 2007 1.06
65 Treatment of severe hemorrhagic cystitis after allogeneic stem cell transplantation with palifermin, a recombinant human keratinocyte growth factor. Biol Blood Marrow Transplant 2007 1.05
66 Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med 2007 1.04
67 Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun 2003 1.04
68 Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry. Leuk Res 2012 1.03
69 Topological analysis of a putative virB8 homologue essential for the cag type IV secretion system in Helicobacter pylori. Int J Med Microbiol 2003 1.01
70 The RecA protein of Helicobacter pylori requires a posttranslational modification for full activity. J Bacteriol 2004 1.01
71 Type IV secretion systems in pathogenic bacteria. Int J Med Microbiol 2002 1.01
72 Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun 2003 1.01
73 Topology and membrane interaction of Helicobacter pylori ComB proteins involved in natural transformation competence. Int J Med Microbiol 2003 1.00
74 Structure of Helicobacter pylori catalase, with and without formic acid bound, at 1.6 A resolution. Biochemistry 2004 0.99
75 Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 2008 0.99
76 Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes. Exp Hematol 2008 0.98
77 CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Mult Scler 2010 0.98
78 Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals. Br J Haematol 2006 0.98
79 Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. Leuk Res 2012 0.98
80 Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes. Eur J Haematol 2009 0.97
81 Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin. Proc Natl Acad Sci U S A 2012 0.97
82 Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol Microbiol 2002 0.97
83 Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica 2007 0.97
84 Regulation of Helicobacter pylori adherence by gene conversion. Mol Microbiol 2012 0.96
85 Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia. Leuk Res 2008 0.96
86 Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation. Eur J Haematol 2003 0.95
87 Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia. Oncogene 2005 0.94
88 Analysis of the type IV secretion system-dependent cell motility of Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 2004 0.94
89 Production of ammonium by Helicobacter pylori mediates occludin processing and disruption of tight junctions in Caco-2 cells. Microbiology 2005 0.93
90 CagI is an essential component of the Helicobacter pylori Cag type IV secretion system and forms a complex with CagL. PLoS One 2012 0.93
91 Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms. Haematologica 2002 0.93
92 Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors. Arch Neurol 2011 0.92
93 Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. Int J Cancer 2004 0.91
94 Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One 2010 0.91
95 Identification, structure and mode of action of a new regulator of the Helicobacter pylori HP0525 ATPase. EMBO J 2007 0.91
96 Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell Microbiol 2013 0.90
97 A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report. J Med Case Rep 2008 0.90
98 Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome. Int J Hematol 2009 0.89
99 Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival. Haematologica 2009 0.89
100 PKC-dependent endocytosis of the Helicobacter pylori vacuolating cytotoxin in primary T lymphocytes. Cell Microbiol 2010 0.89
101 The role of natalizumab in hematopoietic stem cell mobilization. Expert Opin Biol Ther 2009 0.89
102 Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles. J Virol Methods 2005 0.88
103 P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support. Int J Cancer 2002 0.88
104 Combinatorial hexapeptide ligand libraries (ProteoMiner): an innovative fractionation tool for differential quantitative clinical proteomics. Arch Physiol Biochem 2009 0.88
105 A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma. Transfusion 2006 0.88
106 Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma. Biol Blood Marrow Transplant 2013 0.87
107 Sticky socks: Helicobacter pylori VacA takes shape. Trends Microbiol 2008 0.86
108 Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives. Semin Oncol 2002 0.86
109 Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Leuk Res 2007 0.86
110 Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine. Leuk Res 2006 0.85
111 A comprehensive analysis of Helicobacter pylori plasticity zones reveals that they are integrating conjugative elements with intermediate integration specificity. BMC Genomics 2014 0.85
112 Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model. Int J Med Microbiol 2007 0.85
113 The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol 2008 0.85
114 Novel activities of the Helicobacter pylori vacuolating cytotoxin: from epithelial cells towards the immune system. Int J Med Microbiol 2004 0.85
115 The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameter. Biol Blood Marrow Transplant 2011 0.85
116 The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway. Apoptosis 2011 0.84
117 Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid. Clin Epigenetics 2011 0.84
118 Multiple pathways of plasmid DNA transfer in Helicobacter pylori. PLoS One 2012 0.83
119 The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation. Immunogenetics 2012 0.83
120 Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cells. Mech Ageing Dev 2007 0.83
121 Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesis. Angiogenesis 2006 0.83
122 Differential gene expression underlying the functional distinctions of primary human CD34+ hematopoietic stem and progenitor cells from peripheral blood and bone marrow. Ann N Y Acad Sci 2003 0.83
123 X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis 2006 0.83
124 Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes. Mol Cell Proteomics 2013 0.83
125 Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro. Helicobacter 2012 0.82
126 Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphoma. Ann Hematol 2006 0.82
127 Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts. Leuk Res 2012 0.82
128 Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 2006 0.82
129 T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16. Cancer Immunol Immunother 2012 0.82
130 Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma. Haematologica 2004 0.82
131 Dynamics of the Cag-type IV secretion system of Helicobacter pylori as studied by bacterial co-infections. Cell Microbiol 2013 0.81
132 Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia. Transfusion 2011 0.81
133 Sorafenib treatment in 13 patients with acute myeloid leukemia and activating FLT3 mutations in combination with chemotherapy or as monotherapy. Acta Haematol 2010 0.81
134 Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood 2003 0.81
135 ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum. Arch Physiol Biochem 2010 0.81
136 Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation. Expert Opin Drug Metab Toxicol 2011 0.80
137 Plerixafor enables successful hematopoietic stem cell collection in an extensively pretreated patient with testicular cancer. Acta Haematol 2010 0.80
138 Characterization of the translocation-competent complex between the Helicobacter pylori oncogenic protein CagA and the accessory protein CagF. J Biol Chem 2013 0.80
139 Cell surface sialylation and ecto-sialyltransferase activity of human CD34 progenitors from peripheral blood and bone marrow. Glycoconj J 2004 0.80
140 Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy. Leuk Res 2009 0.80
141 Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia. Leuk Lymphoma 2009 0.79
142 Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation. Transplantation 2002 0.79
143 H pylori infection causes chronic pancreatitis in Mongolian gerbils. World J Gastroenterol 2007 0.79
144 Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine. Ann Hematol 2009 0.79
145 Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome. Ann Hematol 2013 0.79
146 Helicobacter pylori vacuolating cytotoxin inhibits duodenal bicarbonate secretion by a histamine-dependent mechanism in mice. J Infect Dis 2009 0.78
147 Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector. Cancer Gene Ther 2003 0.78
148 [Differentiation potential of stem cells from bone marrow]. Med Klin (Munich) 2006 0.78
149 LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy. Eur J Haematol 2005 0.78
150 Cryptic plasmids in Helicobacter pylori: putative functions in conjugative transfer and microcin production. Int J Med Microbiol 2004 0.78
151 [Practice of recognizing benzene-caused occupational diseases in 2006]. Med Klin (Munich) 2008 0.78
152 Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera. Ann N Y Acad Sci 2005 0.78
153 Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells. Stem Cells 2007 0.77
154 Comparison of PCR with other diagnostic techniques for the detection of H. pylori infection in patients presenting with gastroduodenal symptons in Nigeria. Int J Mol Epidemiol Genet 2011 0.77
155 Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer. Clin Cancer Res 2005 0.77
156 [Paradigm change in the assessment of myeloid and lymphoid neoplasms associated with occupational benzene exposure]. Med Klin (Munich) 2009 0.77
157 Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides. Cancer Gene Ther 2002 0.77
158 cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humans. Nucl Med Biol 2008 0.76
159 Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning. Exp Hematol 2002 0.76
160 Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantation. Leuk Res 2008 0.76
161 The nonsteroidal anti-inflammatory drug Exisulind selectively induces apoptosis via JNK in secondary acute myeloid leukemia after myelodysplastic syndrome. Cell Cycle 2005 0.76
162 Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation. Hematol Oncol 2007 0.76
163 The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system. Haematologica 2014 0.76
164 The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells. Exp Hematol 2013 0.76
165 Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression. J Virol Methods 2002 0.76
166 Molecular biology of hematopoietic stem cells. Vitam Horm 2003 0.76
167 Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006 0.76
168 Clozapine mobilizes CD34+ hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia. J Clin Psychopharmacol 2010 0.76
169 The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells. Ann Hematol 2011 0.75
170 Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS. Br J Haematol 2006 0.75
171 MST1-dependent vesicle trafficking regulates neutrophil transmigration through the vascular basement membrane. J Clin Invest 2016 0.75
172 Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma. Exp Hematol 2006 0.75
173 Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor cells from patients with BCR-ABL-positive CML in chronic phase and blast crisis. Leuk Res 2006 0.75
174 Erratum: Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. Nat Microbiol 2016 0.75
175 Fanconi anaemia - response to Manoharan. Br J Haematol 2006 0.75
176 Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA. Thromb Haemost 2009 0.75
177 Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study. Hematol Oncol 2008 0.75
178 Prognostic molecular markers in myelodysplastic syndromes. Expert Rev Hematol 2009 0.75
179 Recombinant bacterial ghosts: versatile targeting vehicles and promising vaccine candidates. Int J Med Microbiol 2004 0.75
180 Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases. Wien Klin Wochenschr 2009 0.75
181 Molecular monitoring of minimal residual disease in patients with multiple myeloma. Hematology 2004 0.75
182 Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow. Ann Hematol 2013 0.75
183 Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support. Stem Cells 2002 0.75
184 Diagnostic methods for the detection of Helicobacter pylori in Nigeria. Trop Gastroenterol 2010 0.75
185 Mass spectrometry-based proteomics and its potential use in haematological research. Arch Physiol Biochem 2009 0.75
186 Erratum: Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nat Microbiol 2016 0.75